Medical Devices: Page 176


  • Hospitals call on medtech to ease interoperability by boosting security

    "Medical device manufacturers must do more to confront the privacy challenges that unsecurable devices may pose to hospitals and health systems," the American Hospital Association and six other groups said in a report.

    By Meg Bryant • Jan. 23, 2019
  • J&J hit with $120M bill in 46-state hip implant marketing settlement

    South Carolina and Texas led the effort alleging Johnson & Johnson mischaracterized the longevity and safety of two DePuy Orthopaedics hip replacement products no longer on the market.

    By Maria Rachal • Jan. 23, 2019
  • Boston Scientific's Farapulse pulsed field ablation device. Explore the Trendline
    Image attribution tooltip
    Permission granted by Boston Scientific
    Image attribution tooltip
    Trendline

    New medical devices are reshaping the medtech industry

    From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.

    By MedTech Dive staff
  • Medtronic data show no paclitaxel-mortality link amid FDA warnings

    A study of peripheral artery disease patients treated using paclitaxel-coated balloons differed in conclusions from a meta-analysis that prompted an agency safety alert last week.

    By Jan. 23, 2019
  • Image attribution tooltip
    Stanford University
    Image attribution tooltip

    Illumina TruSight assay gets FDA breakthrough designation

    The DNA sequencing company is seeking clearance of the assay as a companion diagnostic.

    By Jan. 23, 2019
  • Image attribution tooltip
    Milken Institute
    Image attribution tooltip

    FDA expands Abbreviated 510(k) guidance, seeks predicate input

    FDA Thursday extended the comment period by 30 days for its request for feedback on its proposal to overhaul the 510(k) program to encourage use of more modern predicate devices.

    By David Lim • Updated April 12, 2019
  • Abbott misses sales expectations despite device, diagnostic unit growth

    The medical device unit had the strongest quarter of four divisions, with double-digit growth in sales of diabetes, electrophysiology and structural heart products fueling its performance.

    By Jan. 23, 2019
  • M&A, robotics among medtech growth drivers for 2019: Moody's

    At the same time, slowing economies in both developed and developing countries could constrain volumes and pricing in the sector.

    By Jan. 22, 2019
  • Verily Study Watch gets FDA nod for EKG

    Unlike the FDA-cleared EKG on Apple Watch, the Google-backed company's Study Watch is a prescription-only device.

    By Jan. 22, 2019
  • Bigfoot could shake up insulin delivery market, analyst says

    Medtronic, Dexcom and Insulet will have to contend with the developer of insulin-delivery devices targeted for launch next year, Jefferies predicts.

    By Jan. 22, 2019
  • J&J posts $27B in 2018 medical device sales in slight bump

    Though fourth quarter sales were down 4.4% compared to 2017, the device unit managed 1.1% yearly operational sales growth for 2018.

    By Maria Rachal • Jan. 22, 2019
  • Image attribution tooltip
    Adobe Stock
    Image attribution tooltip

    NESTcc plans pay-for services once FDA funding ends

    Once a business plan is in place, the Medical Device Innovation Consortium's real-world evidence center intends to create products and services to sell to the medical device industry. 

    By Jan. 22, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    FDA flags mortality risk of paclitaxel with stents, balloons for PAD

    The letter to physicians follows a study identifying increased risk of death for patients two years after treatment for peripheral artery disease with a drug-coated balloon or drug-eluting stent.

    By Jan. 18, 2019
  • LivaNova highlights studies into efficacy, value of sutureless aortic valve

    The research suggests the valve, Perceval, may have advantages over competing technologies. 

    By Jan. 18, 2019
  • Image attribution tooltip
    Photo by rawpixel on Unsplash
    Image attribution tooltip

    BD, Mercy ally to use clinical data to boost device use

    The agreement follows similar deals between the health system and J&J and Medtronic. BD also on Thursday morning reaffirmed its 2019 revenue growth guidance of 8.5% to 9.5%.

    By Jan. 17, 2019
  • Abbott inks Cephea buyout to boost mitral valve pipeline

    The takeover gives Abbott another valve replacement device to rival those owned by Edwards and Medtronic.

    By Jan. 17, 2019
  • Mayo, Arizona State team up to found medtech startup accelerator

    The six-month program is designed to connect startups with investors and physicians.

    By Jan. 17, 2019
  • Image attribution tooltip
    David Lim
    Image attribution tooltip

    Top House Democrat to focus on diagnostics revamp, drug prices in 2019

    With Democrats now in power, the new chair of a key oversight subcommittee laid out her priorities, including proposals she argues will bolster the Affordable Care Act.

    By David Lim • Jan. 17, 2019
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA clears energy tools for TransEnterix robotic surgery system

    The company has received FDA 510(k) clearance for a set of advanced energy instruments that can be used with its Senhance robotic surgical system.

    By Jan. 16, 2019
  • Medtronic links patients' pacemakers with their smartphones

    The MyCareLink Heart mobile app is compatible with the company's BlueSync technology-enabled pacemakers and eliminates the need for other remote monitoring hardware.

    By Jan. 16, 2019
  • Medtech therapeutic areas to track in 2019

    Cardiovascular health, diabetes and oncology diagnostics are among the products with greatest consumer and investor interest.

    By Maria Rachal • Jan. 15, 2019
  • Abbott heart device for premature babies wins FDA approval

    The device for sealing a hole in the heart of premature infants ​is smaller than a pea and can treat newborns weighing as little as 2 pounds.

    By Jan. 15, 2019
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    Edwards Lifesciences pays Boston Scientific $180M to settle multiple patent disputes

    Edwards will make a one-time payment to Boston and the companies will drop all other patent suits and appeals related to their current portfolios of heart technologies.

    By Maria Rachal • Updated Jan. 15, 2019
  • FDA clears absorbable foot and ankle implant

    Ossio said its bioabsorbable orthopaedic fixation implant for foot and ankle conditions, made from a mineral fiber matrix, integrates into the surrounding anatomy in 18 to 24 months.

    By Jan. 15, 2019
  • Wound therapy device wins FDA authorization

    The product eliminates the need to use gauze or foam when applying negative pressure to wounds.

    By Jan. 15, 2019
  • Jefferies predicts upbeat 2019 medtech outlook

    As the new year gets underway, the investment bank identifies growth catalysts for eight medtechs.

    By Jan. 14, 2019